Publication: Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).
dc.contributor.author | Martino, Alessandro | |
dc.contributor.author | Sainz, Juan | |
dc.contributor.author | Buda, Gabriele | |
dc.contributor.author | Jamroziak, Krzysztof | |
dc.contributor.author | Reis, Rui Manuel | |
dc.contributor.author | García-Sanz, Ramón | |
dc.contributor.author | Jurado, Manuel | |
dc.contributor.author | Ríos, Rafael | |
dc.contributor.author | Szemraj-Rogucka, Zofia | |
dc.contributor.author | Marques, Herlander | |
dc.contributor.author | Lesueur, Fabienne | |
dc.contributor.author | Moreno, Victor | |
dc.contributor.author | Orciuolo, Enrico | |
dc.contributor.author | Gemignani, Federica | |
dc.contributor.author | Landi, Stefano | |
dc.contributor.author | Rossi, Anna Maria | |
dc.contributor.author | Dumontet, Charles | |
dc.contributor.author | Petrini, Mario | |
dc.contributor.author | Campa, Daniele | |
dc.contributor.author | Canzian, Federico | |
dc.contributor.authoraffiliation | [Martino,A; Campa,D; Canzian,F] Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. [Sainz,J; Jurado,M; Ríos,R] Genomic Oncology Area, Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research (GENYO), Granada. Department of Hematology, Virgen de las Nieves University Hospital, Granada, Spain. [Buda,G; Orciuolo,E; Petrini,M] Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, University of Pisa, Pisa, Italy. [Jamroziak,K; Szemraj-Rogucka,Z] Department of Hematology, Medical University of Lodz, Lodz, Poland. [Reis,RM; Marques,H] Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal. [García-Sanz,R] University Hospital of Salamanca, Universidad de Salamanca-Centro de Investigación del Cáncer, Salamanca, Spain. [Lesueur,F] Genetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France. [Moreno,V] IDIBELL-Catalan Institute of Oncology, CIBERESP and University of Barcelona, Barcelona, Spain. [Gemignani,F; Landi,S; Rossi,AM] Department of Biology, Section of Genetics, University of Pisa, Pisa, Italy. [Dumontet,C] INSERM UMR 1052/CNRS 5286, Laboratoire de Cytologie Analytique, Faculté de Medecine Rockefeller, Université Claude Bernard Lyon I, Lyon, France. [Reis,RM] Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. | es |
dc.contributor.funder | Collection of blood samples from Spain, patients from Granada area and DNA extraction was partially supported by grants P08-CVI-4116 from Consejería de Salud de la Junta de Andalucia (Sevilla, Spain) and PI081051 from Fondo de Investigaciones Sanitarias (Madrid, Spain). Collection of blood samples from Polish patients and controls from Lodz area and DNA extraction was supported by a grant from Polish Ministry of Science and Higher Education (No.NN402178334). | |
dc.date.accessioned | 2013-11-15T10:24:58Z | |
dc.date.available | 2013-11-15T10:24:58Z | |
dc.date.issued | 2012-03 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't; Review; | es |
dc.description.abstract | There is strong evidence suggesting the presence of a genetic component in the aetiology of multiple myeloma (MM). However no genetic risk factors have been unequivocally established so far. To further our understanding of the genetic determinants of MM risk, a promising strategy is to collect a large set of patients in a consortium, as successfully done for other cancers. In this article, we review the main findings in the genetic susceptibility and pharmacogenetics of MM and present the strategy of the IMMEnSE (International Multiple Myeloma rESEarch) consortium in contributing to determine the role of genetic variation in pharmacogenetics and in MM risk. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int. J. Oncol. 2012; 40(3):625-38 | es |
dc.identifier.doi | 10.3892/ijo.2011.1284 | |
dc.identifier.essn | 1791-2423 | |
dc.identifier.issn | 1019-6439 | |
dc.identifier.pmid | 22159523 | |
dc.identifier.uri | http://hdl.handle.net/10668/1379 | |
dc.journal.title | International journal of oncology | |
dc.language.iso | en | |
dc.publisher | Spandidos Publications | es |
dc.relation.publisherversion | http://www.spandidos-publications.com/ijo/40/3/625 | es |
dc.rights.accessRights | open access | |
dc.subject | IMMEnSE consortium, | es |
dc.subject | Multiple myeloma | es |
dc.subject | SNPs | es |
dc.subject | Genetic susceptibility | es |
dc.subject | Hharmacogenetics | es |
dc.subject | Humanos | es |
dc.subject | Variación Genética | es |
dc.subject | Farmacogenética | es |
dc.subject | Factores de Riesg0 | es |
dc.subject | Mieloma Múltiple | es |
dc.subject | Epidemiología Molecular | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Molecular Epidemiology | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Plasma Cell::Multiple Myeloma | es |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biology::Genetics::Pharmacogenetics | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Susceptibility::Genetic Predisposition to Disease | es |
dc.title | Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Martino_Genetics.pdf
- Size:
- 515.98 KB
- Format:
- Adobe Portable Document Format
- Description: